LIN SUE-JEAN - Insider Non-Derivative Transactions at Arcutis Biotherapeutics, Inc. (ARQT) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jun 14, 2024, LIN SUE-JEAN's relationship to Arcutis Biotherapeutics, Inc. (ARQT) is Director, and currently has 19,126 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other ARQT insiders.
Data Source: SEC.
LIN SUE-JEAN - Insider Non-Derivative Transactions of ARQT Common Stock
LIN SUE-JEAN - Insider Non-Derivative Transactions at ARQT
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jun 15, 2024 | Acquisition -- (Common Stock) | 10139 | 0 | 19126 |
| Jun 1, 2023 | Acquisition -- (Common Stock) | 4375 | 0 | 8987 |